TBX3, a member of the ancient and evolutionary conserved T-box transcription factor family, is a critical developmental regulator of several structures including the heart, mammary glands, limbs and lungs. Indeed, mutations in the human TBX3 lead to ulnar mammary syndrome which is characterized by several clinical malformations including hypoplasia of the mammary and apocrine glands, defects of the upper limb, areola, dental structures, heart and genitalia. In contrast, TBX3 has no known function in adult tissues but is frequently overexpressed in a wide range of epithelial and mesenchymal derived cancers. This overexpression greatly impacts several hallmarks of cancer including bypass of senescence, apoptosis and anoikis, promotion of proliferation, tumour formation, angiogenesis, invasion and metastatic capabilities as well as cancer stem cell expansion. The debilitating consequences of having too little or too much TBX3 suggest that its expression levels need to be tightly regulated. While we have a reasonable understanding of the mutations that result in low levels of functional TBX3 during development, very little is known about the factors responsible for the overexpression of TBX3 in cancer. Furthermore, given the plethora of oncogenic processes that TBX3 impacts, it must be regulating several target genes but to date only a few have been identified and characterised. Interestingly, while there is compelling evidence to support oncogenic roles for TBX3, a few studies have indicated that it may also have tumour suppressor functions in certain contexts. Together, the diverse functional elasticity of TBX3 in development and cancer is thought to involve, in part, the protein partners that it interacts with and this area of research has recently received some attention. This review provides an insight into the significance of TBX3 in development and cancer and identifies research gaps that need to be explored to shed more light on this transcription factor.

No abstract

No abstract

<p>FLAG-TBX3 overexpression in C33A, C33A HPV18 E6/7, CaSki and HeLa cells confirmed by western blotting.</p>

<p>Establishment of CaSki and HeLa cervical cancer cell culture model in which TBX3 was stably overexpressed.</p>

<p>HPV18 E6 and E7 oncogene mRNA expression in the E6, E7 and E6/E7 stably transfected cells compared to the wild type and empty vector controls.</p>

<p>HPV18 E6 and E7 oncogene mRNA expression in the E6, E7 and E6/E7 stably transfected cells compared to the wild type and empty vector controls.</p>

<p>Establishment of CaSki and HeLa cervical cancer cell culture model in which TBX3 was stably overexpressed.</p>